Mass General Brigham Ventures LLC

10/02/2026 | Press release | Distributed by Public on 10/02/2026 15:30

Research spotlight: Digital psychoeducation shows promise as support tool for newly diagnosed borderline personality disorder

Research spotlight: Digital psychoeducation shows promise as support tool for newly diagnosed borderline personality disorder

Published October 2, 2026

Q: What challenges or unmet needs make this study important?

Borderline personality disorder (BPD) is a prevalent and disabling condition that's associated with an increased risk of suicide, yet specialized, evidence-based treatments are typically effective. The problem is that the demand for focused care far exceeds the availability of such treatments, like Dialectical Behavioral Therapy (DBT). This mismatch between supply and demand, which exists globally, can cause substantial delays between the onset of BPD symptoms, formal diagnosis and referral to proper treatment. The irony of these long treatment waitlists is that "frantic efforts to avoid abandonment" is a hallmark of BPD.

Recently revised American Psychiatric Association (APA) treatment guidelines recommend routine diagnostic assessment and psychoeducation, alongside psychosocial interventions targeting key mechanisms of BPD. We hypothesized that delivering the psychoeducation component digitally could significantly increase the scalability of care for people with newly diagnosed BPD, both by reducing the need to train professionals, and by providing patients with 24/7 access to credible information from the comforts of their own homes and schedules.

Q: What central question(s) were you investigating?

One goal of our study was to evaluate whether prescribing patients 10 online educational videos about BPD immediately after their diagnosis was safe, feasible and could reduce symptom severity. We also hoped to learn whether these videos could increase patients' basic knowledge of the condition compared to generic mental health psychoeducation.

Additionally, we explored the feasibility of an online clinical measurement protocol incorporating standard self-assessment, Ecological Momentary Assessment (EMA, brief daily check-ins that captured participants' emotions, behaviors and social experiences in real time) and neuropsychological testing. When administered to patients with BPD, we asked, could this digital protocol assess their symptom severity, cause improvements in their BPD knowledge and cognitive functioning and address underlying disorder mechanisms, all without face-to-face clinical intervention?

We also wondered whether automated descriptive feedback reports could add a layer of personalization to this online assessment.

Q: What methods or approach did you use?

Participants were randomized to receive either 10 online psychoeducation videos focused on BPD or general mental health. The BPD videos were informed by Good Psychiatric Management (GPM) and covered foundational information about the disorder, including its symptoms and prevalence, as well as GPM's conceptualization of BPD as a disorder characterized by interpersonal hypersensitivity.

Videos were delivered once daily on weekdays. All participants completed online assessments at four time points, including self-report measures of BPD symptoms, personality functioning and loneliness, as well as neuropsychological measures. In addition, participants completed a 30-day EMA protocol, starting at baseline, that included questions about social interactions and brief cognitive assessments.

Those assigned to the BPD psychoeducation videos were further randomized to receive either personalized feedback based on their assessment results or no feedback.

Q: What did you find?

Our protocol combining online BPD-focused psychoeducation with personalized feedback was safe, feasible and acceptable to individuals with newly diagnosed BPD. There were no significant differences between groups in rates of emergency department visits, hospitalizations, other escalations in level of care or dropouts.

Although there were not statistically significant differences between groups in reductions in BPD symptom severity, participants who received BPD-focused psychoeducation reported greater satisfaction with the intervention and improvements in BPD-related knowledge compared to those in the control group. Moreover, participants who received BPD-focused psychoeducation with personalized feedback demonstrated significantly greater improvements in self-clarity and understanding than controls.

Finally, participants who received BPD-focused education and personalized feedback appeared better able to spend time alone without worsening symptoms, while the opposite pattern was seen in the control group.

Q: What are the real-world implications, particularly for patients?

Online BPD-focused psychoeducation may provide a safe and feasible first step toward receiving informed care, helping to address the gap between the onset or diagnosis of BPD and access to effective treatment. In our study, the psychoeducational videos were delivered via YouTube links and are now publicly available online. Many individuals with BPD already seek information about their diagnosis online, underscoring the importance of directing patients toward accessible, evidence-informed resources that provide accurate and clinically appropriate information.

However, psychoeducation alone may not be sufficient. Our findings suggest that the addition of feedback based on online assessments may be necessary to elicit more substantial improvements in functioning.

Q: What are some other projects in BPD your team is leading?

In many countries around the world, BPD remains stigmatized, clinician training is limited and language barriers restrict access to educational and training resources, making appropriate care difficult. These gaps are particularly concerning in South Korea, which has one of the highest suicide rates among Organisation for Economic Co-operation and Development (OECD) member countries, yet BPD is rarely diagnosed there and access to evidence-based treatment remains limited.

A recent review paper published by our team describes the clinical characteristics of BPD in South Korea and the current state of diagnosis and treatment there, as well as several practical steps for improving the country's BPD care.

Building on that review is our GPDI Korea initiative, a collaboration between the Gunderson Personality Disorders Institute (GPDI) and Gangnam Severance Hospital and Yonsei University College of Medicine, aimed at improving BPD awareness and care in South Korea. We are running public and clinician awareness campaigns to address stigma surrounding BPD and providing Korean-language educational resources through the GPDI website. This initiative also includes several planned follow-up studies.

primary

external

Read the paper

Online psychoeducation and assessment for borderline personality disorder as a first step of care

Authorship: In addition to Choi-Kain, Mass General Brigham authors include Destiny Crisp, Margaret Mosby and Boyu Ren. Additional authors include Sam Mermin, Grace Murray, Julia Jurist, Sara Masland and Laura Germine.

Paper cited: Choi-Kain, LW., et al. "Online psychoeducation and assessment for borderline personality disorder as a first step of care: A pilot study assessing safety, feasibility, and mechanisms of change." PLoS One. DOI: https://doi.org/10.1371/journal.pone.0353836

Funding: This study was funded by the Brain and Behavior Research Foundation 2021 NARSAD Young Investigator Grant (30053) and the McLean Eric Dorris Translational Research Grant. Funding from both grants was awarded to Choi-Kain. The funders did not have a role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Media contact

Ryan Jaslow
Program Director, External Communications
[email protected]

About Mass General Brigham

Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation's leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.

Mass General Brigham Ventures LLC published this content on October 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2026 at 21:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]